S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon

scPharmaceuticals (SCPH) Short Interest Ratio & Short Volume

$4.56
+0.05 (+1.11%)
(As of 04/19/2024 ET)

scPharmaceuticals Short Interest Data

Current Short Volume
4,620,000 shares
Previous Short Volume
4,650,000 shares
Change Vs. Previous Month
-0.65%
Dollar Volume Sold Short
$23.19 million
Short Interest Ratio / Days to Cover
19.5
Last Record Date
March 31, 2024
Outstanding Shares
36,050,000 shares
Float Size
23,450,000 shares
Short Percent of Float
19.70%
Today's Trading Volume
166,627 shares
Average Trading Volume
207,237 shares
Today's Volume Vs. Average
80%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling scPharmaceuticals ?

Sign up to receive the latest short interest report for scPharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SCPH Short Interest Over Time

SCPH Days to Cover Over Time

SCPH Percentage of Float Shorted Over Time

scPharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/20244,620,000 shares $23.19 million -0.7%19.7%19.5 $5.02
3/15/20244,650,000 shares $27.11 million -2.9%19.8%19.2 $5.83
2/29/20244,790,000 shares $28.84 million +3.0%20.5%19.8 $6.02
2/15/20244,650,000 shares $26.41 million -0.4%19.9%14.5 $5.68
1/31/20244,670,000 shares $22.88 million -0.2%20.0%12.8 $4.90
1/15/20244,680,000 shares $27.94 million -1.3%19.9%13 $5.97
12/31/20234,740,000 shares $29.72 million -1.5%20.2%13.3 $6.27
12/15/20234,810,000 shares $27.51 million -26.1%20.4%13.7 $5.72
11/30/20236,510,000 shares $35.41 million -1.2%27.6%19.8 $5.44
11/15/20236,590,000 shares $33.21 million +0.9%28.0%27.8 $5.04
10/31/20236,530,000 shares $34.94 million -4.3%27.7%27.7 $5.35
10/15/20236,820,000 shares $42.35 million -0.2%29.0%29.2 $6.21
9/30/20236,830,000 shares $48.63 million -0.6%29.0%27.3 $7.12
9/15/20236,870,000 shares $48.23 million +2.4%29.2%23.6 $7.02
8/31/20236,710,000 shares $51.53 million -0.5%28.5%16.7 $7.68
8/15/20236,740,000 shares $53.65 million +10.1%28.7%15.6 $7.96
7/31/20236,120,000 shares $51.59 million -4.4%N/A13.7 $8.43
7/15/20236,400,000 shares $53.50 million +8.7%N/A14.5 $8.36
6/30/20235,890,000 shares $60.02 million +16.6%N/A12.8 $10.19
6/15/20235,050,000 shares $54.34 million +12.7%N/A11.4 $10.76
5/31/20234,480,000 shares $47.58 million +10.1%N/A12.8 $10.62
5/15/20234,070,000 shares $46.93 million +16.6%N/A9.6 $11.53
4/30/20233,490,000 shares $34.41 million +1.8%18.0%6.6 $9.86
4/15/20233,430,000 shares $32.83 million +3.6%17.6%6.1 $9.57
3/31/20233,310,000 shares $30.02 million +1.9%17.8%6.3 $9.07
3/15/20233,250,000 shares $22.39 million +3.8%17.5%6.4 $6.89
2/28/20233,130,000 shares $23.48 million -5.2%17.7%6.4 $7.50
2/15/20233,300,000 shares $30.53 million +73.7%16.4%6.8 $9.25
1/31/20231,900,000 shares $11.74 million +11.8%9.4%5.6 $6.18
1/15/20231,700,000 shares $10.78 million +36.0%8.4%7 $6.34
12/30/20221,250,000 shares $8.96 million +17.9%6.2%2.9 $7.17
12/15/20221,060,000 shares $6.87 million +122.7%5.1%2.3 $6.48
11/30/2022475,900 shares $3.49 million -20.3%2.7%1.1 $7.33
11/15/2022597,100 shares $3.93 million +23.9%3.4%1.5 $6.58
10/31/2022482,000 shares $2.57 million -22.9%3.4%1.4 $5.34
10/15/2022625,500 shares $3.38 million +221.9%4.4%1.9 $5.40
9/30/2022194,300 shares $1.27 million +67.5%1.4%0.7 $6.52
9/15/2022116,000 shares $545,200.00 -3.3%0.8%2 $4.70
8/31/2022120,000 shares $702,000.00 +15.9%0.9%1.4 $5.85
8/15/2022103,500 shares $669,645.00 +14.9%0.8%1.3 $6.47
Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

SCPH Short Interest - Frequently Asked Questions

What is scPharmaceuticals' current short interest?

Short interest is the volume of scPharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 4,620,000 shares of SCPH short. 19.70% of scPharmaceuticals' shares are currently sold short. Learn More on scPharmaceuticals' current short interest.

What is a good short interest ratio for scPharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SCPH shares currently have a short interest ratio of 20.0. Learn More on scPharmaceuticals's short interest ratio.

Which institutional investors are shorting scPharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of scPharmaceuticals: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for scPharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.70% of scPharmaceuticals' floating shares are currently sold short.

Is scPharmaceuticals' short interest increasing or decreasing?

scPharmaceuticals saw a decrease in short interest in March. As of March 31st, there was short interest totaling 4,620,000 shares, a decrease of 0.6% from the previous total of 4,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is scPharmaceuticals' float size?

scPharmaceuticals currently has issued a total of 36,050,000 shares. Some of scPharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. scPharmaceuticals currently has a public float of 23,450,000 shares.

How does scPharmaceuticals' short interest compare to its competitors?

19.70% of scPharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to scPharmaceuticals: Regulus Therapeutics Inc. (9.44%), Renovaro Inc. (2.27%), Inventiva S.A. (0.11%), Skye Bioscience, Inc. (0.29%), Adicet Bio, Inc. (9.36%), Incannex Healthcare Inc. (0.78%), CervoMed Inc. (0.60%), Veru Inc. (6.77%), Trevi Therapeutics, Inc. (1.51%), Gossamer Bio, Inc. (4.77%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short scPharmaceuticals stock?

Short selling SCPH is an investing strategy that aims to generate trading profit from scPharmaceuticals as its price is falling. SCPH shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against scPharmaceuticals?

A short squeeze for scPharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SCPH, which in turn drives the price of the stock up even further.

How often is scPharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SCPH, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:SCPH) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners